308 filings
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
6 Feb 24
Entry into a Material Definitive Agreement
4:47pm
S-8
HRGN
Harvard Apparatus Regenerative Technology, Inc.
16 Nov 23
Registration of securities for employees
2:06pm
10-Q
2023 Q3
HRGN
Harvard Apparatus Regenerative Technology, Inc.
Quarterly report
13 Nov 23
11:59am
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
20 Jul 23
Amendments to Articles of Incorporation or Bylaws
1:25pm
8-K
d4c 23bo33ma5
19 Jul 23
Submission of Matters to a Vote of Security Holders
5:13pm
8-K/A
aao qzeqpvsimuiq
10 Jul 23
Unregistered Sales of Equity Securities
3:47pm
DEFR14A
4dh026vr0
7 Jun 23
Revised proxy
3:41pm
DEFA14A
33lwuguaqv3514sy23e
7 Jun 23
Additional proxy soliciting materials
2:51pm
D
rvrxdrk5
14 Apr 23
$6.01 mm in equity, sold $6.01 mm, 14 investors
6:55am
8-K
863 aumr2r9r
10 Apr 23
Biostage Appoints Ron Packard to Board of Directors
9:30am
8-K
uguq sz8je
6 Apr 23
Biostage Announces $6 Million Financing to Advance Clinical Trial
10:10am
8-K
fbku366
14 Mar 23
Unregistered Sales of Equity Securities
4:30pm
8-K
lqm8noi tw87r6
7 Mar 23
Biostage Announces Chairman and CEO Transition
4:30pm
RW
fep 49ezabp88lcbpspu
1 Feb 23
Registration withdrawal request
5:00pm
8-K
d6m 8ss9gfy
26 Jan 23
Unregistered Sales of Equity Securities
2:53pm
8-K
60xvb50g8lhzcl
12 Jan 23
Unregistered Sales of Equity Securities
9:23am